[The question of fibrinolytic therapy of myocardial infarction in practice].
Systemic application of streptokinase in fibrinolytic therapy of acute myocardial infarction was reported and the advantages over intracoronary application were discussed.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*
D000925:Anticoagulants; D006493:Heparin; D013300:Streptokinase
Zur Frage der fibrinolytischen Therapie des Myokardinfarktes in der Praxis.